Bart Howe, MBA is CEO of HealthMark Group of Dallas, TX. He is also president of the Association of Health Information Outsourcing Services (AHIOS).
Tell me about yourself and the company….
Continue Reading
by Healthcare M&A 06/23/2023 Leave a Comment
What You Should Know:
Quest Diagnostics announced that it has completed its $450M acquisition of Haystack Oncology.Haystack Oncology has developed a highly sensitive minimal-residual disease (MRD) testing technology, based…
Continue Reading
Blue Earth Diagnostics and PETNET Solutions, a Siemens Healthineers Company, have announced the availability of POSLUMA (Flotufolastat F 18) Injection for PET Imaging of Prostate Cancer in the United States. POSLUMA, an optimized PET…
Continue Reading
Personal diagnostics and health platform Thriva has announced a two-year nationwide partnership, to bring its diagnostic testing to Superdrug Health Clinics across the country.The partnership will enable Superdrug to offer Thriva’s health diagnostics to…
Continue Reading
The antibody index (AI) is a measure of local antibody synthesis in the central nervous system (CNS) and represents an important and growing tool in neurological diagnostics. Determination of the AI supports diagnosis of…
Continue Reading
Walmart has partnered with Simple HealthKit, a diagnostics startup, to offer at-home testing kits for sexual wellness, diabetes detection, and respiratory health on its website. Customers can order the kits, perform the tests at…
Continue Reading
Engineers at the University of California San Diego have developed a low-cost cuffless blood pressure monitor. The device is a clip that attaches over a smartphone camera and flash. The user presses their finger…
Continue Reading
Calif.-based diagnostics startup Simple HealthKit announced it is partnering with Walmart to make its home diagnostic test kits for diabetes, sexual wellness and respiratory wellness available to customers via the retail chain’s website. Simple HeathKit’s…
Continue Reading
Cue Health has received FDA de novo authorization for its at-home COVID-19 test, becoming the first company to achieve this milestone. The test, called Cue COVID-19 Molecular Test, can detect genetic material from the…
Continue Reading
Home diagnostics company Cue Health announced its received FDA de novo authorization for its at-home COVID test dubbed Cue COVID-19 Molecular Test. The Cue COVID-19 Molecular Test detects genetic material from the SARS-CoV-2 virus and…
Continue Reading
